PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2023-02-28

Date Title Company
28-Feb-2023 New Phase 3 data presented at WORLDSymposiumâ„¢ reinforce Nexviazyme® (avalglucosidase alfa) as potential new standard of care for all people living with late-onset Pompe disease Sanofi
28-Feb-2023 Alfa Laval Launches Best-in-class Heat Exchanger for Hygienic Applications Alfa Laval
28-Feb-2023 Almirall opens the doors of its R&D centre to the biotech ZeClinics Almirall
28-Feb-2023 HUTCHMED Completes Patient Enrollment of Phase II Registration Trial of Amdizalisib in Follicular Lymphoma in China HUTCHMED
28-Feb-2023 Obesity in pregnant women could alter the structure and function of the placenta increasing the risk of poor health outcomes for both mother and baby The Physiological Society
28-Feb-2023 Final Results Spectral MD Holdings, Ltd
28-Feb-2023 Genprex Announces Groundbreaking Data from Non-Human Primate Study Evaluating Novel Gene Therapy to Treat Type 1 Diabetes at 16th Annual International Conference on Advanced Technologies & Treatment for Diabetes 2023 Genprex
28-Feb-2023 UK faces £50bn economic hit due to spiralling medicines levy Association of the British Pharmaceutical Industry (ABPI)
28-Feb-2023 Rare disease community call for their unified voice to be heard in the fight for equitable care Sanofi
28-Feb-2023 Relief Therapeutics Recognizes Rare Disease Day and Announces U.S. Availability of New PKU GOLIKE Bars Relief Therapeutics Holding SA
28-Feb-2023 Global Drug Eruptions Treatment Market to reach US$ 7.1 billion by 2033, Antihistamines to account for 41% of all Treatments | FMI Study MARKITWIRED
28-Feb-2023 The Global Eosinophilic Granulomatosis with Polyangiitis Treatment Market Is Expected to Register Growth at 5.2% CAGR through 2033 | FMI Study MARKITWIRED
28-Feb-2023 Promising Results from Gene Delivery and Enzyme Replacement Therapies to Revolutionize the USA Fucosidosis Therapeutics Market | FMI Predicts 25% of Revenue to Come from North America MARKITWIRED
28-Feb-2023 Eisenmenger Complex Management Market to reach US$ 12.9 billion in 2033, Endothelin Receptors to account for 48.1% of all Drugs | FMI Study MARKITWIRED